Price T Rowe Associates Inc Enovis Corp Transaction History
Price T Rowe Associates Inc
- $812 Billion
- Q1 2025
A detailed history of Price T Rowe Associates Inc transactions in Enovis Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 39,376 shares of ENOV stock, worth $1.24 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,376
Previous 38,750
1.62%
Holding current value
$1.24 Million
Previous $1.7 Million
11.52%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ENOV
# of Institutions
321Shares Held
64MCall Options Held
1.67MPut Options Held
473K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.21MShares$196 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.11MShares$193 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.43MShares$171 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO3.52MShares$111 Million0.09% of portfolio
-
Davenport & CO LLC3.07MShares$97 Million0.72% of portfolio
About Enovis CORP
- Ticker ENOV
- Exchange NYSE
- Sector Industrials
- Industry Specialty Industrial Machinery
- Shares Outstandng 54,129,500
- Market Cap $1.71B
- Description
- Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...